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UPRmt regulation and output: a stress response mediated 
by mitochondrial-nuclear communication
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The mitochondrial network is not only required for the production of energy, essential cofactors and amino acids, 
but also serves as a signaling hub for innate immune and apoptotic pathways. Multiple mechanisms have evolved to 
identify and combat mitochondrial dysfunction to maintain the health of the organism. One such pathway is the mi-
tochondrial unfolded protein response (UPRmt), which is regulated by the mitochondrial import efficiency of the tran-
scription factor ATFS-1 in C. elegans and potentially orthologous transcription factors in mammals (ATF4, ATF5, 
CHOP). Upon mitochondrial dysfunction, import of ATFS-1 into mitochondria is reduced, allowing it to be trafficked 
to the nucleus where it promotes the expression of genes that promote survival and recovery of the mitochondrial 
network. Here, we discuss recent findings underlying UPRmt signal transduction and how this adaptive transcription-
al response may interact with other mitochondrial stress response pathways.
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Introduction
When healthy, the highly dynamic and interconnected 
mitochondrial network provides the cell with energy in 
the form of ATP, cofactors such as heme and iron-sulfur 
clusters, amino acids, as well as nucleotides [1-3]. Mito-
chondria also serve as hubs for many signaling cascades 
including those regulating apoptosis and innate immunity 
[4-6]. During mitochondrial dysfunction many of these 
vitally important mitochondrial processes are compro-
mised. With age, a notable increase in mitochondrial dys-
function occurs in otherwise healthy individuals and this 
decline is exacerbated in age-related neurological and 
cardiovascular diseases such as Parkinson’s Disease and 
coronary artery disease, respectively [7-9]. The underly-
ing causes of mitochondrial dysfunction in these scenar-
ios include an accumulation of damaged mitochondrial 
genomes (mtDNA) that normally encode 13 essential 
oxidative phosphorylation (OXPHOS) components re-
quired for the function of respiratory complexes I, III and 
IV, as well as the ATP synthase [10]. 
The remainder of the mitochondrial proteome is com-
prised of nuclear-encoded proteins (~1 500 in humans) 
that are synthesized by cytosolic ribosomes and targeted 
to each compartment within the mitochondrial network 
and subsequently imported via the TOM (translocase of 
the outer membrane) and TIM (translocase of the inner 
membrane) channels [11, 12]. Nuclear-encoded proteins 
are also susceptible to age-associated damage as they 
can become misfolded and aggregate [13], which can be 
exacerbated by locally produced reactive oxygen species 
(ROS) during OXPHOS-mediated ATP production [14]. 
Notably, mitochondrial defects are often pleiotropic. For 
example, OXPHOS or mitochondrial proteostasis pertur-
bations reduce the rate of mitochondrial protein import 
by reducing the proton gradient or impairing mitochon-
drial chaperones, both of which must be maintained for 
efficient import [15].
Cellular responses to mitochondrial dysfunction
Organisms have evolved multiple mechanisms to rec-
ognize and resolve dysfunction within the mitochondrial 
network. Collectively, these mechanisms culminate with 
a response that recovers organelles that are salvageable 
and degrades organelles that are beyond repair, ultimate-
ly yielding a healthier mitochondrial network. 
Severely damaged mitochondria are identified and 
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Figure 1 Mitochondrial stress response pathways. (A) Recognition and selective degradation of damaged mitochondria is 
mediated by mitophagy. The kinase PINK1 is stabilized specifically on damaged mitochondria where it recruits the ubiquitin 
ligase Parkin, which ubiquitinates multiple mitochondrial outer membrane proteins. Ubiquitinated mitochondria are then en-
gulfed by autophagosomes and trafficked to lysosomes where they are degraded. (B) The kinase GCN2, which is activated 
during mitochondrial dysfunction, mediates translation attenuation during mitochondrial dysfunction by phosphorylating the 
translation initiation factor eIF2α, which serves to reduce the influx of proteins into mitochondria. (C) Accumulation of mislo-
calized mitochondrial proteins in the cytosol stimulates proteasome activity to limit the accumulation of the toxic proteins in 
a pathway dubbed UPRam (unfolded protein response activated by mistargeted proteins). (D) The UPRmt is regulated by the 
competing organelle targeting sequences in the transcription factor ATFS-1. If ATFS-1 is imported into the mitochondrial ma-
trix via the MTS, the transcription factor is degraded. However, if ATFS-1 cannot be imported due to mitochondrial dysfunc-
tion, it is trafficked to the nucleus, via the NLS, to activate transcription.
degraded via the process known as mitophagy (Figure 
1A) [16]. Prior to the initiation of mitophagy, severely 
dysfunctional portions of the mitochondrial network are 
isolated through fission to prevent stress from diffusing 
throughout the entire network [17]. Mitophagy requires 
PINK1, a kinase that is imported into healthy mitochon-
dria and ultimately degraded [18, 19]. However, when 
mitochondrial import is perturbed, PINK1 is stabilized 
on the outer mitochondrial membrane (OMM) where 
it phosphorylates ubiquitin [20, 21]. PINK1 also phos-
phorylates the ubiquitin ligase Parkin, recruiting it to the 
cytosolic face of the OMM where it poly-ubiquitinates 
multiple proteins [22-24]. Poly-ubiquitination serves to 
recruit machinery that engulfs the damaged organelle 
into an autophagosome, which is subsequently trafficked 
to lysosomes for degradation, thus ridding damaged 
compartments of the mitochondrial network [25, 26]. 
While mitophagy may represent a last resort for indi-
vidual organelles, additional stress responses are in place 
to both limit the damage in defective mitochondria and 
facilitate the recovery of salvageable organelles. The vast 
majority of the mitochondrial proteome is synthesized 
on cytosolic ribosomes and imported into mitochondria, 
where each protein is processed and assembled with the 
help of mitochondrial-localized chaperones [12]. If not 
processed efficiently, the load of imported proteins can 
perturb mitochondrial proteostasis and impair essential 
mitochondrial activities. Cytosolic protein synthesis can 
be modulated during mitochondrial stress by the kinase 
GCN2, which phosphorylates the eukaryotic initiation 
factor alpha (eIF2α) [27], as a branch of the integrated 
stress response (ISR). GCN2 is likely stimulated by mi-
tochondrial stress via reduced amino acids, increased 
ROS or ribosome stalling (Figure 1B) [28-30]. The 
Andrew Melber and Cole M Haynes
283
www.cell-research.com | Cell Research | SPRINGER NATURE
phosphorylation of eIF2α results in a decrease in protein 
synthesis, reducing the number of nascent peptides being 
imported into the mitochondria [31]. 
Reduced protein synthesis may also limit ribosome 
stalling during co-translational import into mitochondria. 
Recent work has demonstrated that Vms1, a protein that 
accumulates on damaged mitochondria by interacting 
with oxidized sterols [32, 33], resolves stalled ribosomes 
interacting with the TOM channel [34]. In the absence of 
Vms1, nascent protein fragments emerging from stalled 
mitochondrial-localized ribosomes are not accessible to 
the ubiquitin ligase Listerin due to the tight association 
with the TOM channel. Upon recruitment to dysfunction-
al mitochondria, Vms1 prevents the non-canonical addi-
tion of C-terminal alanine and threonine (CAT) tails to 
the nascent peptide as the mitochondrial matrix proteo-
stasis machinery is unable to process CAT-tailed proteins 
for degradation. In sum, Vms1 localization to the outer 
membrane of damaged mitochondria prevents the aggre-
gation of nascent protein fragments in mitochondria that 
can severely impair mitochondrial function.
A consequence of mitochondrial dysfunction is re-
duced protein import efficiency, which results in the 
accumulation of mislocalized mitochondrial proteins in 
the cytosol. A response, known as UPRam (UPR activated 
by protein mistargeting), promotes the degradation of the 
highly toxic mislocalized proteins by increasing protea-
some activity and reducing protein synthesis (Figure 1C) 
[35, 36]. 
The focus of this review is on how cells regulate an 
adaptive transcriptional response during mitochondrial 
dysfunction to promote cell survival and recovery of 
the mitochondrial network known as the mitochondrial 
unfolded protein response (UPRmt). This pathway was 
initially discovered in mammalian cells, and further 
characterized in C. elegans [37]. The UPRmt is coordinat-
ed by multiple factors including the transcription factor 
ATFS-1 (Figure 1D). ATFS-1 is a transcription factor that 
promotes the expression of nuclear-encoded genes such 
as mitochondrial chaperones and proteases, ROS de-
toxification enzymes, and mitochondrial protein import 
components [38]. These induced proteins presumably en-
ter functional and dysfunctional mitochondria in the cell 
to preserve function in healthy organelles and recover 
activity in damaged compartments. In addition to UPRmt 
regulation, the functional interactions between UPRmt 
and translation attenuation, ribosome quality control and 
the UPRam will be discussed.
Regulation and transcriptional outputs of the UPRmt
UPRmt activation was first described in cultured 
mammalian cells exposed to ethidium bromide, which 
perturbs mitochondrial function by depleting mtDNA, 
resulting in the induction of transcripts encoding mito-
chondrial chaperones and proteases [39]. Similarly, over-
expression of mutant ornithine transcarbamylase, lacking 
a segment required for proper processing and folding 
(∆OTC), in the mitochondrial matrix elicited a similar 
transcriptional response, indicating a relationship linking 
mitochondrial function, proteostasis perturbations in mi-
tochondria and UPRmt activation [37]. Subsequent work 
in C. elegans and mammalian systems has identified 
multiple components required for UPRmt activation, in-
cluding sensors of mitochondrial dysfunction, regulators 
of mitochondrial-to-nuclear communication, chromatin 
regulators, and transcription factors.
Perturbations that activate the UPRmt
Numerous chemical, genetic and proteotoxic stresses 
have been shown to activate the UPRmt, providing clues 
to the regulatory mechanisms and the physiologic or 
pathologic scenarios where the pathway may be import-
ant [39-41]. As mentioned above, the disruption of mito-
chondrial proteostasis by the expression of a mitochon-
drial-localized misfolded protein is capable of activating 
the UPRmt [37]. Presumably the misfolded proteins 
overwhelm the activity of mitochondrial chaperones in 
the matrix, which is essential for multiple mitochondrial 
activities including protein import. As such, the depletion 
of mitochondrial chaperones or proteases is also capable 
of activating the UPRmt [40]. 
The impairment of genes involved in diverse aspects 
of mitochondrial function also activates the UPRmt, such 
as mitochondrial protein import (impairment of tim-23), 
OXPHOS (impairment of complex III or IV), coenzyme 
Q biogenesis (clk-1 inhibition), or lipid biogenesis (acl-
12 impairment) [28, 40, 42-44]. In addition, exposure 
to paraquat, a superoxide generator that perturbs respi-
ratory chain function, causes UPRmt activation [42] as 
does the mitochondrial ribosome inhibitor doxycycline 
[45]. Importantly, all of these perturbations likely reduce 
mitochondrial import efficiency. By impairing TIM-23, 
an essential protein import component, transport into the 
matrix is directly impaired [42]. Respiratory chain per-
turbations potentially impair import by increasing ROS 
production and by depleting the proton gradient across 
the mitochondrial inner membrane. Recently, it has be-
come appreciated that the expression of aggregate-prone 
proteins in the cytosol, such as mutant Huntingtin pro-
tein, linked to the onset of Huntington’s disease, also 
activates the UPRmt [46]. How the disruption of proteo-
stasis in the cytosol activates the UPRmt is unclear, how-
ever, it is clear that mitochondrial function is disrupted in 
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diseases attributed to aggregate-prone proteins [7, 47]. 
Numerous studies suggest that UPRmt activation oc-
curs in a variety of human diseases. Mitochondrial dis-
ease occurs in 1 of ~3 000 individuals and assessment 
of these patients may provide direct insight into UPRmt 
function [48]. A cohort of patients with mitochondrial 
disease-associated myopathy (mitochondrial myopathy) 
correlated positively with an increase in FGF-21 [49], 
a gene known to be upregulated during mitochondrial 
stress where the UPRmt is activated [50, 51]. Additionally, 
the upregulation of genes indicative of an activated UP-
Rmt has been observed in mouse models of mitochondrial 
disease [52-54]. In addition to mitochondrial diseases, 
neurodegenerative conditions, including Alzheimer’s dis-
ease (AD), are associated with mitochondrial dysfunction 
[7, 55]. Recently, it has been shown in AD patient cohorts 
that an increase in the expression of UPRmt-induced genes 
corresponded with increasing severity of the disease [56]. 
This includes induced UPRmt genes, such as the mito-
chondrial chaperone Hspd1 (Hsp60) and the mitochon-
drial protease Yme1L1 in brain tissue of AD patients [56, 
57]. These studies in patients and disease models suggest 
a use for UPRmt genes as biomarkers for mitochondrial 
disease [49]. Furthermore, the different stressors are in-
formative for our mechanistic understanding of UPRmt 
activation. Notably, many of the stressors that activate 
the UPRmt perturb mitochondrial protein import; this 
commonality between stressors provides mechanistic in-
sight into the activation process. 
Coupling mitochondrial dysfunction to nuclear tran-
scription
In C. elegans, the UPRmt is regulated by the basic 
leucine zipper (bZIP) transcription factor ATFS-1, 
which contains both a mitochondrial targeting sequence 
(MTS) and a nuclear localization sequence (NLS) [58]. 
The presence of dual subcellular localization sequences 
enables the transcription factor to mediate mitochondri-
al-to-nuclear communication [42]. Under homeostatic 
conditions, ATFS-1 is efficiently imported into the mi-
tochondrial matrix and degraded by the protease LON. 
However, under mitochondrial dysfunction conditions, 
mitochondrial import of ATFS-1 is reduced, causing it to 
accumulate in the cytosol. Because ATFS-1 harbors a nu-
clear localization signal, it then traffics to the nucleus to 
activate the transcriptional response (Figure 2A). Thus, 
cells likely utilize mitochondrial import efficiency as an 
indicator of general mitochondrial function using ATFS-
1 as both a sensor and a mitochondria-to-nucleus sig-
naling mechanism. Upon nuclear accumulation, ATFS-1 
activates the transcription of over 500 genes that impact 
diverse cellular activities (Table 1) [38, 42, 59]. 
Once ATFS-1 is imported into the mitochondrial ma-
trix, its MTS is cleaved and the remainder of the protein 
is degraded, suggesting that mitochondrial import effi-
ciency is a key negative regulator of UPRmt activation 
[42]. Multiple studies have demonstrated that diverse 
forms of mitochondrial dysfunction reduce mitochondrial 
protein import efficiency [18, 35, 42, 60]. The percentage 
of ATFS-1 that fails to be imported into mitochondria 
traffics to the nucleus and activates the nuclear transcrip-
tional response [42]. In support of this model, mutations 
that cause amino acid substitutions within the MTS of 
ATFS-1 prevent the protein from being imported into the 
mitochondrial matrix, and result in constitutive UPRmt 
activation [61]. Thus, UPRmt activation occurs when the 
import efficiency of the mitochondrial network is re-
duced.
One aspect of the UPRmt that remains unclear is that 
if mitochondrial import of ATFS-1 is reduced, how are 
those gene products induced by ATFS-1 such as mito-
chondrial chaperones and proteases imported into the 
dysfunctional mitochondrial network? This issue is 
partially resolved by the ATFS-1-mediated induction of 
genes encoding components of the mitochondrial import 
complexes such as timm-17 and timm-23 [42]. In addi-
tion, import of UPRmt-induced gene products is likely 
biased towards competent or healthier organelles (Figure 
2A). However, this still does not address how or wheth-
er the UPRmt recovers dysfunctional mitochondria. One 
possibility relates to the strength of the MTS on ATFS-1 
relative to those proteins induced during the UPRmt such 
as mitochondrial chaperones and proteases [62]. The 
program MitoFates analyzes amino acid composition, 
including net positive charge, to predict the likelihood 
that a specific amino terminal sequence will be imported 
into mitochondria [63]. Interestingly, MitoFates suggests 
that ATFS-1 has a significantly weaker MTS than the 
mitochondrial-targeted chaperones and proteases induced 
by ATFS-1 (Figure 2B). This comparison suggests that 
the relatively weak MTS on ATFS-1 may allow the tran-
scription factor to serve as a sensor of mitochondrial im-
port efficiency. While a percentage of ATFS-1 may fail to 
be imported into dysfunctional mitochondria, the strong 
MTSs on mitochondrial chaperones and proteases may 
permit import into dysfunctional mitochondria to re-es-
tablish proteostasis and promote organelle recovery.
UPRmt activation requires mitochondrial stress-induced 
chromatin remodeling 
The importance of chromatin structure in the regu-
lation of transcription is well established [64]. Inter-
estingly, recent studies demonstrate that chromatin is 
specifically remodeled during mitochondrial dysfunc-
Andrew Melber and Cole M Haynes
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Figure 2 Model by which mitochondrial import efficiency of ATFS-1 and gene products induced by ATFS-1 promote mito-
chondrial network recovery. (A) The transcription factor ATFS-1 harbors both a mitochondrial targeting sequence (MTS) and 
a nuclear localization sequence (NLS). ATFS-1 is efficiently imported into healthy mitochondria (green), however, import effi-
ciency is reduced by OXPHOS or mitochondrial proteostasis perturbations that cause mitochondrial dysfunction (yellow, red). 
If ATFS-1 fails to be imported into mitochondria, it is trafficked to the nucleus where it induces transcription of mitochondrial 
protective genes including mitochondrial chaperones and proteases, antioxidants as well as mitochondrial protein import 
components. In turn, mitochondrial import of the protective gene products promotes organelle stabilization and recovery. 
(B) Relative to the proteins induced during the UPRmt, the program Mitofates [63] predicts that ATFS-1 has a substantially 
weaker mitochondrial signal sequence. We hypothesize that a weak MTS allows ATFS-1 to be sensitive to modest mitochon-
drial dysfunction and translocate to the nucleus. In turn, the strong MTSs in those proteins induced by ATFS-1 can still enter 
dysfunctional mitochondria with reduced import efficiency to recover function. HSP-6, HSP-60 and DNJ-10 are mitochondrial 
chaperones, MPPA-1 is a subunit of the mitochondrial presequence processing protease, PPGN-1 is a matrix-localized prote-
ase, GLRX-5 is a glutaredoxin that functions in mitochondrial iron-sulfur cluster biogenesis, MRPS-14 is a subunit of the mi-
tochondrial ribosome, TSFM-1 is a mitochondrial translational elongation factor, all of which are induced during mitochondrial 
dysfunction by ATFS-1. NUO-1, SDHB-1 and ATP-2 are all subunits of the OXPHOS complexes, none of which are activated 
by the UPRmt (complexes I, II and V, respectively).
tion to promote UPRmt activation [65, 66]. The histone 
methyltransferase, MET-2 in concert with LIN-65 [65], 
along with two jumonji domain histone demethylases, 
JMJD-3.1 and JMJD-1.2 [66], were recently found to be 
required for UPRmt activation. Both the histone methyl-
transferase and histone demethylase activities are stimu-
lated by mitochondrial dysfunction. Interestingly, MET-
2 and LIN-65 promote global chromatin condensation, 
whereas the histone demethylases maintain the promoters 
of UPRmt-induced genes in an open or transcriptionally 
competent state. This chromatin state is further stabi-
lized by the homeobox protein DVE-1 and ubiquitin-like 
protein UBL-5, both of which are also required for UP-
Rmt activation [65, 67, 68]. Interestingly, JMJD-3.1 and 
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Table 1 Genes induced during UPRmt in both C. elegans and mammalian models 
C. elegans regulated genes
  Gene Function References
Mitochondrial protein homeostasis dnj-10 Mitochondrial DnaJ, protein chaperone [38, 42, 59]
 hsp-6 Mitochondrial Hsp70, protein chaperone [38, 59]
 ppgn-1 Paraplegin AAA protease (mitochondrial) [38, 59]
 ymel-1 Mitochondrial AAA protease [38, 42]
Mitochondrial protein import tomm-20 Translocase of the outer membrane subunit [38, 59]
 timm-17 Translocase of the inner membrane subunit [38, 42, 59]
Mitochondrial dynamics drp-1 Dynamin-related protein, mitochondrial fission  [38, 42, 59]
 mff-2 Mitochondrial fission factor  [38, 42, 59]
Innate immunity abf-2 Antimicrobial peptide [42, 104]
 lys-2 Secreted lysosome [42, 104]
Transcription factors atfs-1 bZIP transcription factor, UPRmt regulator [38, 42]
 skn-1 bZIP transcription factor, Nrf2 ortholog [38, 42]
Metabolism glna-1 Glutaminase [38, 59]
 clk-1 Coenzyme Q biosynthesis [38, 42, 59]
 ldh-2 Lactate dehydrogenase [38, 42]
Mammalian regulated genes
  Gene Function References
ATF4-regulated ATF5 Transcription factor, UPRmt regulator [72]
 CHOP Transcription factor, UPRmt regulator [71, 72]
 FGF21 Fibroblast growth factor, mitokine [50, 51]
 ASNS Asparagine synthetase [51]
ATF5-regulated mtHSP70 Mitochondrial chaperone [73]
 LON Mitochondrial protease [73]
 HD-5 Antimicrobial peptide [73]
JMJD-1.2 are both necessary and sufficient for UPRmt 
activation and stimulated during mitochondrial dysfunc-
tion in a manner independent of ATFS-1 [66]. Combined, 
these findings demonstrate the requirement for at least 
two inputs to mediate UPRmt activation presumably to ap-
propriately match UPRmt outputs or strength of activation 
to related aspects of animal physiology such as develop-
ment and aging. 
UPRmt regulation via inter-cellular communication
In addition to the cell-autonomous UPRmt regulation 
discussed in previous sections, UPRmt activation can be 
communicated between cells and tissues via endocrine 
signaling. Cell-non-autonomous UPRmt activation has 
been described using multiple neuronal-specific mito-
chondrial stressors, which causes intestinal UPRmt activa-
tion [43]. The expression of an aggregate-prone mutant 
Huntingtin protein in neurons is capable of inducing 
the UPRmt elsewhere in the organism, which requires 
serotonin secretion [46]. Similarly, disruption of mito-
chondrial proteostasis specifically in neurons by utilizing 
CRISPR/Cas9 to impair the protease SPG-7 also resulted 
in intestinal UPRmt activation [69]. This approach led 
to the discovery of a second secreted factor, the neuro-
peptide FLP-2, and a neuronal circuit as being required 
for cell non-autonomous signaling. Endocrine- or mito-
kine-regulated activation of the UPRmt likely serves to 
coordinate activation between tissues, potentially as an 
early warning system linking sensory neurons that prime 
a defense for a future mitochondrial stress in distal tis-
sues.
Mammalian UPRmt regulation
While the initial discovery of the UPRmt was made in 
cultured mammalian cells [39], many of the genes re-
quired for UPRmt activation were identified in C. elegans, 
owing to the relative ease of using the organism to per-
form genetic screens [67, 70]. Interestingly, numerous re-
cent studies in mammalian systems have suggested con-
siderable conceptual and mechanistic overlap between 
UPRmt signaling in the two systems although added 
layers of regulation likely exist in mammals [71-73]. For 
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example, a functional ortholog of ATFS-1 was recently 
discovered. ATF5 is a bZIP transcription factor regulated 
by mitochondrial import efficiency similarly to ATFS-
1. Importantly, ATF5 expression is capable of restoring 
UPRmt activation when expressed in nematodes lacking 
ATFS-1. Furthermore, in cultured cells ATF5 promoted 
OXPHOS and cell growth during mitochondrial dys-
function by inducing expression of several mitochondrial 
chaperone and protease genes [73]. 
In addition to ATF5, at least two other bZIP transcrip-
tion factors, ATF4 and CHOP, are also involved in UPRmt 
activation [72, 74-77]. The relationship between ATF4, 
CHOP and ATF5 during mitochondrial dysfunction re-
mains to be determined. However, it is clear that the ex-
pression of all three transcription factors requires the ISR 
[78, 79]. Hence, the activation of the ISR is necessary for 
UPRmt activation in mammals. ISR activation is mediat-
ed by four kinases that phosphorylate eIF2α in response 
to specific stresses (Figure 3). The ISR kinase PERK re-
sponds to unfolded protein accumulation in the endoplas-
Figure 3 The mammalian UPRmt is intimately associated with the integrated stress response (ISR). During mitochondrial 
dysfunction, the translation initiation factor eIF2α is phosphorylated by one of four eIF2α-specific kinases such as GCN2 (also 
PERK, PKR and HRI). eIF2α phosphorylation results in reduced protein synthesis with a concomitant increase in translation 
of those mRNAs harboring uORFs in the 5′ UTR. The mRNAs encoding the transcription factors CHOP, ATF4 and ATF5 all 
harbor multiple uORFs and are preferentially translated during mitochondrial dysfunction (inset). While the precise relation-
ship between these three transcription factors remains to be determined during mitochondrial stress, all three are required for 
the induction of genes associated with the UPRmt. Both CHOP and ATF4 induce transcription of Atf5. Like ATFS-1 in C. ele-
gans, ATF5 harbors a mitochondrial targeting sequence potentially allowing it to specifically respond to mitochondrial stress 
via reduced mitochondrial protein import efficiency.
288
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mic reticulum, PKR responds to cytosolic double strand-
ed RNA, and HRI is activated by heme depletion [80]. 
GCN2 is activated by mitochondrial stress as well as by 
amino acid depletion, ROS and ribosome stalling [28, 
81]. Phosphorylation of the translation initiation factor 
eIF2α results in reduced protein synthesis, but preferen-
tial synthesis of mRNAs harboring small upstream open 
reading frames (uORFs) in the 5′ untranslated region 
(UTR). 
Selective translation mediated by eIF2α phosphoryla-
tion requires one or more uORFs upstream of a primary 
open reading frame (ORF) in the 5′ UTR (Figure 3, 
inset). Following translation of the first uORF, the ribo-
some dissociates and the 40S subunit continues to scan 
the mRNA for the next ORF. In the absence of eIF2α 
phosphorylation, translation re-initiation occurs quickly 
resulting in translation of the second uORF, which over-
laps the translational start site (methionine) of the pri-
mary ORF, preventing translation. However, if eIF2α is 
phosphorylated, regeneration of the initiation complex is 
slowed, allowing the ribosome to scan through the start 
codon of the second uORF, thus enabling the ribosome to 
engage the primary ORF at a higher rate (Figure 3 inset) 
[81-83]. ATF4, CHOP and ATF5 are three such proteins 
that require eIF2α phosphorylation to be synthesized due 
to the presence of uORFs in the 5′ UTR of the mRNA 
encoding each protein [78, 79, 84, 85]. 
Thus, in mammals, UPRmt activation requires eIF2α 
phosphorylation and is intimately associated with the 
ISR. However, in nematodes the UPRmt does not require 
eIF2α kinases (GCN2) or eIF2α phosphorylation; thus, 
the transcriptional response functions in parallel to the 
regulation of translation [28]. The translational attenua-
tion likely complements the transcriptional response by 
reducing the nascent protein load in the matrix, so that 
UPRmt-induced chaperones and proteases may better 
promote proteostasis in the mitochondria. In mammals, 
translation attenuation is required for the transcriptional 
response to mitochondrial dysfunction.
Beyond all requiring eIF2α phosphorylation, the 
functional relationship between ATF4, CHOP and ATF5 
during mitochondrial stress remains unclear. One possi-
bility is that transcription of ATF5 is regulated by both 
ATF4 and CHOP, which has been shown previously, but 
not in the context of mitochondrial stress [78, 79]. Once 
expressed, ATF5 can subsequently activate mitochon-
drial-specific stress response genes if the mitochondrial 
import of ATF5 is reduced resulting in the nuclear local-
ization of the transcription factor (Figure 3) [73]. How-
ever, CHOP and ATF4 likely contribute to transcriptional 
adaptations to mitochondrial stress directly as well.
Surprisingly, recent work has implicated mTORC1 
(mechanistic target of rapamycin complex 1) in UPRmt 
regulation also via uORF-mediated translation regula-
tion. mTORC1 is a kinase that regulates cellular growth 
in response to cellular nutrition, ATP depletion as well 
as growth factors [86]. mTORC1 activation stimulates 
protein synthesis by phosphorylating S6 kinase [87], and 
impaired mTORC1 results in reduced protein synthe-
sis which coincides with increased autophagy [88, 89]. 
Interestingly, the affected tissues in a mouse model of 
mitochondrial myopathy driven by the accumulation of 
deleterious mtDNAs, had increased mTORC1 activation 
and ATF4 activity [54]. While it is unclear how increased 
mTORC1 activity promotes ATF4 synthesis, it does 
require uORFs [90]. mTORC1 activation in mitochon-
drial myopathy also activated ATF5 along with multiple 
metabolic genes (see below), which were impaired by 
treatment with rapamycin, demonstrating a requirement 
for mTORC1 signaling. This work raises a number of 
exciting questions including how mTORC1 is stimulated 
during mitochondrial dysfunction and how or whether 
mTORC1 interfaces with the ISR to regulate the UPRmt? 
Metabolic adaptations during mitochondrial stress
As mitochondria play a central role in metabolism 
by producing ATP, amino acids, lipids and nucleic acids 
[2, 3], it is perhaps not surprising that the expression of 
many metabolic genes is altered during mitochondrial 
dysfunction via the UPRmt [42]. For example, ATFS-1 
binds the promoters of all glycolysis genes driving their 
induction during mitochondrial stress presumably to al-
low the cell to maintain ATP levels, independent of mito-
chondrial function [38]. Alternatively, ATFS-1 binds the 
promoters of many TCA cycle and OXPHOS genes, but 
represses or limits their transcription during mitochon-
drial stress [38]. Reducing the rate of OXPHOS complex 
biogenesis while maintaining basal metabolic function 
through glycolysis may be protective by (1) restricting 
the amount of ROS byproducts, (2) reducing the load 
of unassembled OXPHOS components in mitochondria 
where proteostasis is perturbed, and (3) to reestablish the 
stoichiometric balance of mitochondrial- and nuclear-en-
coded OXPHOS subunits. 
Metabolic adaption to mitochondrial stress has also 
been observed in mammalian systems. For example, OX-
PHOS-deficient cells isolated from mitochondrial disease 
patients have been shown to survive in culture by in-
creasing glycolysis [91]. In addition, mammalian models 
of mitochondrial stress have shown that ATF4 promotes 
one-carbon metabolism [72, 92]. One-carbon metabolism 
is a general metabolic process providing single-carbon 
units for an array of biosynthetic processes including nu-
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cleotide and amino acid biosynthesis [93]. Furthermore, 
mTORC1, noted above for its role in UPRmt activation, 
promotes purine synthesis [90]. While there is an imme-
diate benefit for maintaining cellular function through 
metabolic alterations, the long-term implications of a 
constitutively active UPRmt that promotes glycolysis and 
biosynthetic processes may be detrimental as this shift is 
characteristic of highly proliferative cells. 
Physiologic roles of mitochondrial stress response
Mitochondrial stress responses during aging
A decline in mitochondrial function with age has been 
well documented in model systems including yeast, 
worms, flies and mice as well as in tissues isolated from 
patients [7, 94-97]. The overall decline in mitochondrial 
function is highlighted by reduced oxygen consumption 
with a corresponding reduction in respiratory complex 
activity [94, 95]. Notably this decline has been attributed 
to the onset of many age-related physiological disorders 
such as Parkinson’s disease and coronary artery disease 
[7-9]. 
One of the first described physiologic roles of the UP-
Rmt was during the lifespan extension caused by modest 
perturbations in OXPHOS. Mutations that perturb OX-
PHOS or coenzyme Q biogenesis in nematodes, flies and 
mice have increased longevity [98-102]. The mitochon-
drial perturbations that lead to the extension of lifespan 
also cause activation of the UPRmt [43]. Importantly, the 
development and increased longevity of these animals 
requires multiple UPRmt components, such as jmjd-3.1, 
haf-1 and dve-1, demonstrating that the pathway is pro-
tective during mitochondrial dysfunction [65, 66, 100, 
103, 104]. Furthermore, UPRmt activation by neuronal 
overexpression of the Jumonji histone demethylase is 
sufficient to extend worm lifespan [66]. However, which 
UPRmt outputs contribute to development and longevity 
remains unclear. 
Along with UPRmt activation [43], mitophagy has also 
been shown to decline with age [105]. Impressively sim-
ilar to increased UPRmt activation, increased mitophagy, 
which is regulated by PINK1 and Parkin, as well as the 
bZIP transcription factor SKN-1 (Nrf2 in mammals), also 
prolongs worm lifespan [106-108]. SKN-1 is induced by 
ATFS-1 during mitochondrial stress as are other mitoph-
agy components [42], suggesting some degree of coordi-
nation between mitophagy and the UPRmt during aging, 
but the precise relationship remains to be determined. 
The UPRmt in aging stem cells 
The role of the UPRmt in longevity has primarily been 
examined in C. elegans, an organism that lacks somatic 
stem cells. Thus, unlike mammals, worms are unable 
to regenerate or replace cells in somatic tissues. Impor-
tantly, the ability to regenerate cell types declines during 
aging due to reduced stem cell function [109-111]. Main-
tenance of the stem cell pool relies on a balance between 
self-renewal, periods of quiescence, and differentiation 
[112-114]. Mitochondria are relatively inactive in qui-
escent stem cells, which primarily rely on glycolysis for 
ATP production. However, upon differentiation mito-
chondrial biogenesis occurs, which is associated with 
an increase in OXPHOS [115, 116]. Numerous reports 
have linked mitochondrial dysfunction with the decline 
in stem cell function during aging [116-118]. For exam-
ple, transgenic mice that accumulate mtDNA mutations 
due to the expression of an mtDNA polymerase lacking 
proofreading activity age prematurely and exhibit stem 
cell dysfunction [117-121]. 
Recent work has suggested a role of the UPRmt and 
the sirtuin SIRT7 in maintaining hematopoietic stem 
cell (HSC) function during aging [122]. During mi-
tochondrial stress, SIRT7 is transcriptionally induced 
and binds to the transcription factor nuclear respiratory 
factor 1 (NRF1), which induces transcripts required for 
mitochondria biogenesis including mitochondrial ribo-
some components. Importantly, SIRT7 represses NRF1’s 
transcription activity. Thus, HSCs lacking SIRT7 have 
a higher degree of mitochondrial biogenesis and mito-
chondrial stress, consistent with increased mitochondrial 
chaperone and protease transcription. Combined, this 
study suggests that SIRT7 serves to re-establish mito-
chondrial proteostasis by reducing the load of newly syn-
thesized mitochondrial proteins. Interestingly, SIRT7-de-
ficient HSCs are prone to aberrant differentiation. Thus, 
SIRT7 represses mitochondrial biogenesis and promotes 
quiescence to maintain the HSC pool. As the levels of 
SIRT7 decrease in aged HSCs, the deregulation of the 
UPRmt may contribute to HSC dysfunction during aging 
[122]. It remains to be determined whether ATF4, ATF5 
or CHOP regulates induction of SIRT7.
Mitochondrial stress responses contribute to deleterious 
mtDNA propagation
The mitochondrial genome (mtDNA) encodes 13 es-
sential OXPHOS components, 2 ribosomal RNAs, and 
22 tRNAs required for mRNA translation in the mito-
chondrial matrix [10]. Most metazoan cells harbor hun-
dreds of copies of mtDNA with 5-10 per organelle [123, 
124]. Steady-state levels of mtDNA are maintained by 
mitochondrial biogenesis which includes mtDNA repli-
cation, requiring the mitochondrial DNA polymerase and 
TFAM, a protein that packages mtDNA into nucleoids 
[125]. In addition, mitophagy affects steady-state mtD-
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NA levels by degrading severely damaged mitochondria 
[125].
Given the high number of mtDNAs per cell, a low 
percentage of deleterious mtDNAs (ΔmtDNA; mutations 
or large deletions) is well tolerated, presumably due to 
the high percentage of wild-type mtDNAs [126]. In fact, 
deep sequencing studies have shown that ΔmtDNAs are 
found in most individuals [127, 128]. However, as cells 
and organisms age, an individual ΔmtDNA can accu-
mulate to a point that perturbs OXPHOS, which impairs 
cellular function [127]. The accumulation of ∆mtDNAs 
likely contributes to the reduction in mitochondrial func-
tion that occurs in aging cells such as neurons or mus-
cles, as well as in cancer cells [129, 130]. The underlying 
mechanisms that impact ∆mtDNA dynamics remain un-
clear, but recent work suggests antagonistic roles for the 
UPRmt and mitophagy.
Perhaps not surprisingly, in a C. elegans model of 
deleterious heteroplasmy (cells containing both wild-
type mtDNA and ΔmtDNA) the UPRmt is activated, as 
the ΔmtDNA lacks the genes required for the expression 
of several OXPHOS subunits [59, 131]. In addition to 
reduced OXPHOS activity, the heteroplasmic worms dis-
played mitonuclear protein imbalance as the OXPHOS 
complex-encoding mRNAs expressed from both wild-
type mtDNAs and ∆mtDNAs were overexpressed rela-
tive to nuclear-encoded subunits, suggesting additional 
proteostasis perturbations [59, 103, 131]. Presumably, 
UPRmt activation occurs in an attempt to maintain pro-
teostasis and promote recovery of mitochondrial dys-
function, similar to what occurs when the mitochondrial 
dysfunction is caused by a toxin or a mutation within 
a nuclear-encoded OXPHOS subunit. Surprisingly, de-
letion of ATFS-1 resulted in a preferential reduction 
in ΔmtDNA, with a concomitant increase in wild-type 
mtDNAs. Furthermore, constitutive activation of the 
UPRmt in the heteroplasmic worm was sufficient to cause 
increased mitochondrial biogenesis, which resulted in a 
preferential increase of ∆mtDNAs relative to wild-type 
mtDNAs [59, 131]. Combined, these data demonstrate 
that a potential consequence of UPRmt activation is the 
propagation of ∆mtDNAs, however, it remains unclear 
how the ∆mtDNA outcompetes wild-type mtDNA.
In contrast to the UPRmt, multiple studies have demon-
strated a role for mitophagy in limiting the accumulation 
of ∆mtDNAs [59, 131-133]. Presumably, the organelles 
in which the ∆mtDNA/mtDNA ratio severely impairs 
OXPHOS are recognized by PINK1 and degraded via 
mitophagy. However, those organelles that contain a 
low percentage of ∆mtDNAs and are able to maintain 
OXPHOS avoid mitophagy. One possible mechanism 
by which the UPRmt maintains ∆mtDNAs is simply by 
maintaining mitochondrial proteostasis and function, 
thus limiting the detection and degradation of mitochon-
dria harboring ∆mtDNAs by mitophagy. Consistent with 
this model, when ATFS-1 is impaired in the absence of 
Parkin, ∆mtDNAs are depleted but not to the levels ob-
served when mitophagy is intact [59, 131].
Conceptually similar results were recently demonstrat-
ed in a mouse model of mitochondrial myopathy caused 
by expression of a mutant version of the mtDNA replica-
tive helicase Twinkle, which causes aberrant accumula-
tion of ∆mtDNAs [54, 134]. The mice accumulate a vari-
ety of ∆mtDNAs in post-mitotic cells, leading to muscle 
OXPHOS deficiency. As discussed above, it was demon-
strated that the UPRmt was induced in these mice in an 
mTORC1-dependent manner. Impressively, mTORC1 
inhibition resulted in reduced UPRmt activation and lim-
ited the accumulation of ∆mtDNAs, which reduced the 
progression of mitochondrial myopathy. These data also 
suggest that ∆mtDNA propagation or accumulation is as-
sociated with mitochondrial biogenesis [54]. Interesting-
ly, in addition to limiting mitochondrial biogenesis, inhi-
bition of mTORC1 also activates mitophagy at a higher 
rate in cells containing heteroplasmic ΔmtDNA [135], 
suggesting a second mechanism by which the UPRmt may 
antagonize mitophagy and promote the accumulation of 
∆mtDNAs. 
Perspective
In this review, we have focused on the role of the UPRmt 
in maintaining the mitochondrial network in model sys-
tems as well as in disease and disease models. While it 
is clear that multiple pathways respond to mitochondrial 
dysfunction and contribute to mitochondrial network ho-
meostasis, data suggesting interactions between the UP-
Rmt, mitophagy, translation modulation and proteasome 
function are only beginning to emerge. For example, 
these responses are activated in response to similar forms 
of mitochondrial stress such as ∆mtDNA heteroplasmy 
or exposure to toxins such as paraquat [131, 136]. Fur-
thermore, numerous reports demonstrate increased eIF2α 
phosphorylation and ISR activation during mitochondrial 
dysfunction, which not only reduces protein synthe-
sis, but is also required for the preferential synthesis of 
ATF4, CHOP and ATF5 that promote recovery of mito-
chondrial network function by adapting transcription [72, 
78, 79, 84]. These findings make it clear that the UPRmt 
in mammals is included within the relatively broad ISR 
requiring eIF2α phosphorylation. However, the mecha-
nism by which the ISR is specified to respond specifical-
ly to mitochondrial stress remains unclear.
Mitochondrial protein import efficiency is a central 
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component common to the regulation of mitophagy, 
the UPRmt and proteasome stimulation. Impaired im-
port causes ATFS-1 and ATF5 to traffic to the nucleus 
to activate the UPRmt, and PINK1 to accumulate in the 
mitochondrial outer membrane to initiate mitophagy, and 
causes the accumulation of mislocalized mitochondrial 
proteins in the cytosol that stimulates proteasome activity 
to maintain cytosolic proteostasis. While OXPHOS and 
mitochondrial proteostasis are often perturbed by condi-
tions that activate these pathways, it is currently unclear 
whether more direct regulation of mitochondrial import 
efficiency plays a role in coordinating these pathways. 
Recent work has demonstrated that TOM complex-me-
diated import is regulated by casein kinase 2 (CK2) and 
protein kinases A (PKA) in yeast. However, whether 
TOM or either kinase is regulated during mitochondrial 
stress is unknown [137-139]. 
Considerable data indicate that UPRmt activation pro-
vides protection during mitochondrial dysfunction; how-
ever, there are also negative consequences of prolonged 
or dysregulated UPRmt activation that occurs in the con-
text of deleterious heteroplasmy. It is clear that UPRmt 
activation promotes development and extends lifespan 
during mild mitochondrial dysfunction, suggesting that 
approaches to enhance UPRmt activation may be useful 
therapeutics. However, several recent reports demon-
strate that prolonged UPRmt activation can exacerbate 
mitochondrial dysfunction caused by deleterious mtDNA 
accumulation [54, 59, 131]. In the context of deleterious 
heteroplasmy, approaches to impair or limit UPRmt acti-
vation improve mitochondrial function. Recent work in 
mice demonstrates that UPRmt inhibition can be achieved 
by treatment with rapamycin, providing optimism for 
future therapeutic approaches. The authors found that 
mitochondrial dysfunction in mouse muscle cells caused 
by mtDNA damage resulted in increased mTORC1 ac-
tivation that was required for increased UPRmt activa-
tion. Importantly, treatment of mice with the mTORC1 
inhibitor rapamycin reduced UPRmt activation, slowing 
mitochondrial myopathy progression caused by the accu-
mulation of deleterious mtDNAs [54]. 
Here, we have reviewed the progress made in under-
standing how cells and organisms evaluate and respond 
to dysfunction in the mitochondrial network and adapt 
transcription accordingly. Included in the UPRmt are not 
only transcripts that promote mitochondrial proteostasis 
and mitochondrial biogenesis, but also metabolic adapta-
tions that promote survival and network recovery. While 
a number of conserved regulatory components required 
to signal the UPRmt and their individual functions have 
been identified, their precise interactions remain to be 
determined. Furthermore, “mitochondrial dysfunction” 
likely encompasses diverse physiological scenarios; how 
the UPRmt is specified or receives inputs during each 
scenario remains to be elucidated. Considering the recent 
pace of UPRmt-related discoveries, we are optimistic that 
the answers to these questions and more will be resolved.
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